24 hours ago
Frankfurt, GermanySenior
Responsibilities
- Design and architect the Orion GenAI Platform for scalable and efficient GenAI product deployment.
- Implement strategies and platform capabilities that accelerate the development and delivery lifecycle of GenAI products.
- Develop standardized technology stacks, reusable components, and best practices across projects.
- Abstract and manage technical complexity so application teams can focus on application-specific functionality.
- Collaborate with cross-functional teams to understand needs and integrate GenAI solutions.
Requirements
- At least 8 years of software engineering experience with relevant GenAI experience focused on generative AI.
- Proven experience designing robust software architectures for large-scale platforms.
- Strong understanding of software development and delivery best practices, including CI/CD pipelines, version control, and testing methodologies.
- Deep knowledge of transformer architectures, embedding models, large language models, Retrieval-Augmented Generation, and AI agents.
- Solid background in data engineering and machine learning engineering; Databricks experience is a plus.
- Extensive experience with cloud platforms, preferably Azure.
- Expertise in advanced Python for developing complex AI models and applications.
- Proficiency in web development technologies, particularly JavaScript.
- Experience with parallel processing and GPU/CUDA programming is nice to have.
- A master’s degree in Machine Learning, Statistics, Computer Science, Physics, Math, or a related field is preferred.
Tech Stack
Categories
About IQVIA
IQVIA provides clinical research services, healthcare data analytics, and technology platforms to pharmaceutical, biotech, medical device, and healthcare organizations. It sells contracted R&D and commercialization services, software, and data subscriptions that help run trials, generate real-world evidence, and guide go-to-market decisions. Formed by the merger of Quintiles and IMS Health, the company is headquartered in Durham, North Carolina and is publicly traded on the NYSE (ticker: IQV).